Covered recipient · General Payments record
ROBERT L STANLEY
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$4,244.20
- Reported across 275 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $283.81 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $64.12 | 3 |
| GlaxoSmithKline, LLC. | $60.76 | 4 |
| ABIOMED | $32.22 | 1 |
| ABBVIE INC. | $24.86 | 1 |
| Janssen Pharmaceuticals, Inc | $19.19 | 1 |
| Amgen Inc. | $17.34 | 1 |
| PFIZER INC. | $16.84 | 1 |
| Acerta Pharma LLC | $16.57 | 1 |
| Lilly USA, LLC | $16.08 | 1 |
| SANOFI-AVENTIS U.S. LLC | $15.83 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $23.04 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124852898 | CMS |
| Abbott Laboratories | $17.07 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124852902 | CMS |
| Abbott Laboratories | $24.01 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124852900 | CMS |
| ABBVIE INC. | $24.86 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106153901 | CMS |
| ABIOMED | $32.22 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142291769 | CMS |
| Amgen Inc. | $17.34 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116148774 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.57 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104338176 | CMS |
| GlaxoSmithKline, LLC. | $13.14 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116237277 | CMS |
| GlaxoSmithKline, LLC. | $13.50 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116332435 | CMS |
| GlaxoSmithKline, LLC. | $17.62 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116319830 | CMS |
| GlaxoSmithKline, LLC. | $16.50 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116372427 | CMS |
| Janssen Pharmaceuticals, Inc | $19.19 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077911407 | CMS |
| Lilly USA, LLC | $16.08 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135370282 | CMS |
| PFIZER INC. | $16.84 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131636412 | CMS |
| SANOFI-AVENTIS U.S. LLC | $15.83 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139612586 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.